<DOC>
	<DOCNO>NCT01607944</DOCNO>
	<brief_summary>Incretin hormone ( GLP-1 GIP ) insulin secretory effect pancreas glucose dependent . Extrapancreatic effect incretin hormone report , however glucose dependency effect examine . In type 2 diabetes , pancreatic endocrine function incretin metabolism impair . The investigator hypothesize extrapancreatic effect incretin hormone glucose depedent dysregulated subject type 2 diabetes . Healthy control subject type 2 diabetic undergo pancreatic clamp . In brief , somatostatin infused inhibit pancreatic endocrine function basal level insulin , glucagon , growth hormone replace via infusion . Metabolic flux study euglycemic hyperglycemic stage pancreatic clamp . Each subject undergo 3 trial involve co-infusion either saline ( Control Trial ) , GLP-1 , GIP . Glucose metabolism assess use 13C-glucose stable isotope methodology combine indirect calorimetry expire breath isotope ratio analysis . Blood flow flow-mediated dilation measure use ultrasound Doppler . Skeletal muscle abdominal adipose biopsy take examine intracellular signalling .</brief_summary>
	<brief_title>Incretins Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Incretins</mesh_term>
	<criteria>age 1860 year BMI 1835 kg/m2 NGT T2DM classify ADA criterion Insulin dependency Smokers History presentation cardiovascular disease , cancer , chronic hematological , renal , hepatic , pulmonary disease Weight loss ( &gt; 2 kg previous 6 month ) Physical activity ( &gt; 150 mins/week )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>